Analysis of the EF-14 phase Ill trial reveals that tumor treating fields alter progression patterns in glioblastoma. Jeyapalan, S. A., Toms, S. A., Hottinger, A., Kleinberg, L., Pollom, E., Soltys, S. G., Glas, M. AMER SOC CLINICAL ONCOLOGY. 2019

View details for DOI 10.1200/JCO.2019.37.15_suppl.2055

View details for Web of Science ID 000487345804437